Free. Unsubscribe any time.
Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics, Inc. filed 38 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 81 transactions and 1,316,107 shares. 38 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-09, came 14 days after the one before it (2026-08-26) and reports 2 transactions against 1 in the filing before it.
- The sales it reports total 8,210 shares, 10,711 fewer than the 18,921 in the filing before it.
- Its 38 plan statements rank 152nd of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 38 filings on file run from 2025-03-17 to 2026-09-09, and state 4 plan adoption dates, from 2024-12-11 to 2026-03-27.
Trades in Rapport Therapeutics, Inc. 81
- Bredt David — 2025-03-14 · S · 8,500 shares
- Bredt David — 2025-04-15 · S · 8,500 shares
- Bredt David — 2025-05-15 · S · 8,500 shares
- Bredt David — 2025-06-16 · S · 8,500 shares
- Bredt David — 2025-07-15 · S · 8,500 shares
- Bredt David — 2025-08-15 · S · 8,300 shares
- Bredt David — 2025-08-15 · S · 200 shares
- Gault Cheryl — 2025-09-08 · S · 5,000 shares
- Bredt David — 2025-09-15 · S · 5,098 shares
- Bredt David — 2025-09-15 · S · 3,402 shares
- Ceesay Abraham — 2025-09-17 · S · 39,435 shares
- Ceesay Abraham — 2025-09-17 · S · 1,400 shares
Adoption dates in Rapport Therapeutics, Inc. 4
- 2024-12-11 — stated in 2 filings
- 2024-12-12 — stated in 18 filings
- 2025-12-10 — stated in 8 filings
- 2026-03-27 — stated in 6 filings
Results prints in Rapport Therapeutics, Inc. 7
- 2025-03-11
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-03-10
- 2026-05-07
- 2026-08-05
Trades before a print in Rapport Therapeutics, Inc. 1
- 0 days before the 2026-05-07 print — 2026-05-07 · S · Third Rock Ventures V, L.P. · 271,495 shares
- 9 days before the 2026-08-05 print — 2026-07-27 · S · Ceesay Abraham · 2,203 shares
- 9 days before the 2026-08-05 print — 2026-07-27 · S · Ceesay Abraham · 7 shares
- 20 days before the 2026-03-10 print — 2026-02-18 · S · Ceesay Abraham · 3,552 shares
- 20 days before the 2026-03-10 print — 2026-02-18 · S · Ceesay Abraham · 2,281 shares
- 20 days before the 2026-03-10 print — 2026-02-18 · S · Ceesay Abraham · 2,983 shares
- 20 days before the 2026-03-10 print — 2026-02-18 · S · Ceesay Abraham · 2,100 shares
- 20 days before the 2026-05-07 print — 2026-04-17 · S · Third Rock Ventures V, L.P. · 426,005 shares
- 20 days before the 2026-05-07 print — 2026-04-17 · S · Yeleswaram Krishnaswamy · 20,225 shares
- 21 days before the 2026-03-10 print — 2026-02-17 · S · Bredt David · 900 shares
- 21 days before the 2026-03-10 print — 2026-02-17 · S · Bredt David · 5,400 shares
- 21 days before the 2026-03-10 print — 2026-02-17 · S · Bredt David · 2,200 shares
Interval to Rapport Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 3within 10 days
- 0shortest, days
- 12no later print
- Third Rock Ventures V, L.P. 2026-05-07 · S · 0 days before the 2026-05-07 print
- Ceesay Abraham 2026-07-27 · S · 9 days before the 2026-08-05 print · Chief Executive Officer
- Ceesay Abraham 2026-07-27 · S · 9 days before the 2026-08-05 print · Chief Executive Officer
Adoption dates Rapport Therapeutics, Inc. states
- 2024-12-11 in 2 filings
- 2024-12-12 in 18 filings
- 2025-12-10 in 8 filings
- 2026-03-27 in 6 filings
Filing text: “10b5-1 trading plan adopted on December 12, 2024”
Reported results dates on file
- 2025-03-11
- 2025-05-08
- 2025-08-07
- 2025-11-06
- 2026-03-10
- 2026-05-07
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.